BISFOS™
Composition:
Each vial contains:
Zoledronic acid IP equivalent to
Zoledronic acid anhydrous 4 mg.
Mannitol IP 220mg.
Sodium Citrate IP 24mg.
(As sterile freeze-dried powder for reconstitution)
INDICATIONS:
Treatment of hypercalcemia of malignancy
Treatment of multiple myeloma
Treatment of bone metastases of solid tumors